Numero quattro: Immunology experts at deal-focused IFM line up $55.5M for the next leg of their drug exploration journey
It’s pipeline priming time at IFM Therapeutics. And they have the money to get the job done.
The immunology experts at the discovery outfit have …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
